Self-testing Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Device, Deployment, End User, Functionality, Solutions

Description

The global self-testing market is projected to grow from $15.0 billion in 2025 to $29.0 billion by 2035, at a compound annual growth rate (CAGR) of 6.8%. Self-testing adoption is expanding at very high volumes across multiple diagnostic categories. More than 500 million people globally live with diabetes, supporting the use of over 10-15 billion blood glucose test strips annually. At-home pregnancy testing remains one of the most widely used diagnostics, with an estimated 100-150 million tests conducted each year worldwide. During the COVID-19 peak period alone, over 5-7 billion rapid antigen self-test kits were distributed globally, accelerating mass consumer acceptance of self-testing. In addition, hundreds of millions of cholesterol, ovulation, and infectious disease rapid tests are used annually, reflecting strong volume-driven demand. These large-scale testing volumes are reinforcing self-care diagnostics as a mainstream component of global healthcare delivery.

The type segment of the self-testing market includes blood glucose tests, pregnancy tests, HIV tests, COVID-19 tests, cholesterol tests, urinary tract infection tests, allergy tests, genetic tests, and others. Among these, blood glucose tests are the leading subsegment due to the rising global prevalence of diabetes and the need for frequent at-home monitoring. Pregnancy tests hold demand owing to ease of use and affordability. Genetic tests are emerging as the fastest-growing segment driven by personalized healthcare and preventive screening. COVID-19 tests continue to contribute steadily post-pandemic, while other tests show consistent adoption supported by growing health awareness and self-care trends.

Market Segmentation
Type	Blood Glucose Tests, Pregnancy Tests, HIV Tests, COVID-19 Tests, Cholesterol Tests, Urinary Tract Infection Tests, Allergy Tests, Genetic Tests, Others
Product	Test Kits, Test Strips, Digital Devices, Wearable Devices, Mobile Applications, Others
Technology	Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Biosensors, Microfluidics, Others
Component	Sensors, Reagents, Software, Display Units, Batteries, Others
Application	Home Care, Point-of-Care, Remote Monitoring, Telehealth, Others
Device	Portable Devices, Handheld Devices, Wearable Devices, Others
Deployment	Standalone Devices, Integrated Systems, Cloud-based Platforms, Others
End User	Individuals, Clinics, Hospitals, Diagnostic Centers, Pharmacies, Others
Functionality	Single-use, Reusable, Connected Devices, Others
Solutions	Diagnostic Solutions, Monitoring Solutions, Data Management Solutions, Others

The product segment includes test kits, test strips, digital devices, wearable devices, mobile applications, and others. Test kits dominate the market due to wide applicability and ease of use in home diagnostics. Test strips hold a significant share, particularly in glucose monitoring, driven by frequent usage. Digital devices are a fast-growing segment supported by connectivity, accuracy, and integration with smartphones. Wearable devices are emerging rapidly due to continuous health monitoring trends. Mobile applications are increasingly used for data tracking, remote monitoring, and telehealth integration, enhancing patient engagement. Other products continue to support niche diagnostic needs across self-testing applications globally.

Geographical Overview

North America is the leading region in the self-testing market driven by strong healthcare infrastructure, high consumer awareness, and widespread adoption of home-based diagnostic solutions. The region benefits from the high prevalence of chronic diseases such as diabetes and cardiovascular disorders, which supports continuous demand for glucose monitoring and other self-test kits. Favorable reimbursement policies, rapid regulatory approvals, and strong presence of key diagnostic companies further strengthen market growth. In addition, increasing preference for preventive healthcare and digital health integration has accelerated adoption. The United States dominates the regional market due to advanced technology and high healthcare spending levels globally.

Asia-Pacific is emerging as the fastest-growing region in the self-testing market, driven by rising healthcare awareness, expanding middle-class population, and increasing access to affordable diagnostic technologies. Rapid urbanization, improving healthcare infrastructure, and government initiatives promoting early disease detection are further supporting market expansion. Countries such as China, India, and Japan are witnessing strong adoption of home-based testing kits for diabetes, infectious diseases, and pregnancy testing. The growing burden of chronic diseases and infectious outbreaks has accelerated demand for convenient, rapid, and cost-effective self-testing solutions. Additionally, increasing penetration of e-commerce and digital health platforms is boosting product accessibility across region markets.

Key Trends and Drivers

Rising Disease Burden and Preventive Healthcare Demand:

The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases is a major driver of the self-testing market. Growing global health burdens have heightened the need for early diagnosis and continuous health monitoring outside traditional clinical environments. Consumers are increasingly adopting self-testing solutions to manage long-term conditions and detect illnesses at an early stage. Rising awareness about preventive healthcare and wellness is also encouraging proactive health management. Additionally, healthcare systems are promoting decentralized diagnostics to reduce hospital load, further accelerating the demand for accurate, affordable, and accessible self-testing products worldwide.

Rise of Multiplex and Rapid Home Testing:

Another major trend in the self-testing market is the growing popularity of multiplex and rapid testing kits that allow users to detect multiple health conditions simultaneously. These advanced kits are widely used for infectious diseases, glucose monitoring, fertility tracking, and vitamin deficiencies, offering quick and reliable results within minutes. The demand for fast turnaround time and minimal clinical dependency is driving innovation in lateral flow assays and point-of-care technologies. Increasing consumer preference for preventive healthcare and early disease detection is further boosting adoption. This trend is expanding accessibility and making self-testing a standard component of home-based healthcare globally.

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Product Code: GIS26806

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Component
2.5 Key Market Highlights by Application
2.6 Key Market Highlights by End User
2.7 Key Market Highlights by Device
2.8 Key Market Highlights by Deployment
2.9 Key Market Highlights by Functionality
2.10 Key Market Highlights by Solutions

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Blood Glucose Tests
- 4.1.2 Pregnancy Tests
- 4.1.3 HIV Tests
- 4.1.4 COVID-19 Tests
- 4.1.5 Cholesterol Tests
- 4.1.6 Urinary Tract Infection Tests
- 4.1.7 Allergy Tests
- 4.1.8 Genetic Tests
- 4.1.9 Others
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Test Kits
- 4.2.2 Test Strips
- 4.2.3 Digital Devices
- 4.2.4 Wearable Devices
- 4.2.5 Mobile Applications
- 4.2.6 Others
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Lateral Flow Assays
- 4.3.2 Immunoassays
- 4.3.3 Molecular Diagnostics
- 4.3.4 Biosensors
- 4.3.5 Microfluidics
- 4.3.6 Others
4.4 Market Size & Forecast by Component (2020-2035)
- 4.4.1 Sensors
- 4.4.2 Reagents
- 4.4.3 Software
- 4.4.4 Display Units
- 4.4.5 Batteries
- 4.4.6 Others
4.5 Market Size & Forecast by Application (2020-2035)
- 4.5.1 Home Care
- 4.5.2 Point-of-Care
- 4.5.3 Remote Monitoring
- 4.5.4 Telehealth
- 4.5.5 Others
4.6 Market Size & Forecast by End User (2020-2035)
- 4.6.1 Individuals
- 4.6.2 Clinics
- 4.6.3 Hospitals
- 4.6.4 Diagnostic Centers
- 4.6.5 Pharmacies
- 4.6.6 Others
4.7 Market Size & Forecast by Device (2020-2035)
- 4.7.1 Portable Devices
- 4.7.2 Handheld Devices
- 4.7.3 Wearable Devices
- 4.7.4 Others
4.8 Market Size & Forecast by Deployment (2020-2035)
- 4.8.1 Standalone Devices
- 4.8.2 Integrated Systems
- 4.8.3 Cloud-based Platforms
- 4.8.4 Others
4.9 Market Size & Forecast by Functionality (2020-2035)
- 4.9.1 Single-use
- 4.9.2 Reusable
- 4.9.3 Connected Devices
- 4.9.4 Others
4.10 Market Size & Forecast by Solutions (2020-2035)
- 4.10.1 Diagnostic Solutions
- 4.10.2 Monitoring Solutions
- 4.10.3 Data Management Solutions
- 4.10.4 Others

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Component
  - 5.2.1.5 Application
  - 5.2.1.6 End User
  - 5.2.1.7 Device
  - 5.2.1.8 Deployment
  - 5.2.1.9 Functionality
  - 5.2.1.10 Solutions
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Component
  - 5.2.2.5 Application
  - 5.2.2.6 End User
  - 5.2.2.7 Device
  - 5.2.2.8 Deployment
  - 5.2.2.9 Functionality
  - 5.2.2.10 Solutions
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Component
  - 5.2.3.5 Application
  - 5.2.3.6 End User
  - 5.2.3.7 Device
  - 5.2.3.8 Deployment
  - 5.2.3.9 Functionality
  - 5.2.3.10 Solutions
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Component
  - 5.3.1.5 Application
  - 5.3.1.6 End User
  - 5.3.1.7 Device
  - 5.3.1.8 Deployment
  - 5.3.1.9 Functionality
  - 5.3.1.10 Solutions
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Component
  - 5.3.2.5 Application
  - 5.3.2.6 End User
  - 5.3.2.7 Device
  - 5.3.2.8 Deployment
  - 5.3.2.9 Functionality
  - 5.3.2.10 Solutions
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Component
  - 5.3.3.5 Application
  - 5.3.3.6 End User
  - 5.3.3.7 Device
  - 5.3.3.8 Deployment
  - 5.3.3.9 Functionality
  - 5.3.3.10 Solutions
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Component
  - 5.4.1.5 Application
  - 5.4.1.6 End User
  - 5.4.1.7 Device
  - 5.4.1.8 Deployment
  - 5.4.1.9 Functionality
  - 5.4.1.10 Solutions
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Component
  - 5.4.2.5 Application
  - 5.4.2.6 End User
  - 5.4.2.7 Device
  - 5.4.2.8 Deployment
  - 5.4.2.9 Functionality
  - 5.4.2.10 Solutions
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Component
  - 5.4.3.5 Application
  - 5.4.3.6 End User
  - 5.4.3.7 Device
  - 5.4.3.8 Deployment
  - 5.4.3.9 Functionality
  - 5.4.3.10 Solutions
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Component
  - 5.4.4.5 Application
  - 5.4.4.6 End User
  - 5.4.4.7 Device
  - 5.4.4.8 Deployment
  - 5.4.4.9 Functionality
  - 5.4.4.10 Solutions
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Component
  - 5.4.5.5 Application
  - 5.4.5.6 End User
  - 5.4.5.7 Device
  - 5.4.5.8 Deployment
  - 5.4.5.9 Functionality
  - 5.4.5.10 Solutions
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Component
  - 5.4.6.5 Application
  - 5.4.6.6 End User
  - 5.4.6.7 Device
  - 5.4.6.8 Deployment
  - 5.4.6.9 Functionality
  - 5.4.6.10 Solutions
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Component
  - 5.4.7.5 Application
  - 5.4.7.6 End User
  - 5.4.7.7 Device
  - 5.4.7.8 Deployment
  - 5.4.7.9 Functionality
  - 5.4.7.10 Solutions
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Component
  - 5.5.1.5 Application
  - 5.5.1.6 End User
  - 5.5.1.7 Device
  - 5.5.1.8 Deployment
  - 5.5.1.9 Functionality
  - 5.5.1.10 Solutions
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Component
  - 5.5.2.5 Application
  - 5.5.2.6 End User
  - 5.5.2.7 Device
  - 5.5.2.8 Deployment
  - 5.5.2.9 Functionality
  - 5.5.2.10 Solutions
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Component
  - 5.5.3.5 Application
  - 5.5.3.6 End User
  - 5.5.3.7 Device
  - 5.5.3.8 Deployment
  - 5.5.3.9 Functionality
  - 5.5.3.10 Solutions
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Component
  - 5.5.4.5 Application
  - 5.5.4.6 End User
  - 5.5.4.7 Device
  - 5.5.4.8 Deployment
  - 5.5.4.9 Functionality
  - 5.5.4.10 Solutions
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Component
  - 5.5.5.5 Application
  - 5.5.5.6 End User
  - 5.5.5.7 Device
  - 5.5.5.8 Deployment
  - 5.5.5.9 Functionality
  - 5.5.5.10 Solutions
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Component
  - 5.5.6.5 Application
  - 5.5.6.6 End User
  - 5.5.6.7 Device
  - 5.5.6.8 Deployment
  - 5.5.6.9 Functionality
  - 5.5.6.10 Solutions
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Component
  - 5.6.1.5 Application
  - 5.6.1.6 End User
  - 5.6.1.7 Device
  - 5.6.1.8 Deployment
  - 5.6.1.9 Functionality
  - 5.6.1.10 Solutions
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Component
  - 5.6.2.5 Application
  - 5.6.2.6 End User
  - 5.6.2.7 Device
  - 5.6.2.8 Deployment
  - 5.6.2.9 Functionality
  - 5.6.2.10 Solutions
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Component
  - 5.6.3.5 Application
  - 5.6.3.6 End User
  - 5.6.3.7 Device
  - 5.6.3.8 Deployment
  - 5.6.3.9 Functionality
  - 5.6.3.10 Solutions
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Component
  - 5.6.4.5 Application
  - 5.6.4.6 End User
  - 5.6.4.7 Device
  - 5.6.4.8 Deployment
  - 5.6.4.9 Functionality
  - 5.6.4.10 Solutions
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Component
  - 5.6.5.5 Application
  - 5.6.5.6 End User
  - 5.6.5.7 Device
  - 5.6.5.8 Deployment
  - 5.6.5.9 Functionality
  - 5.6.5.10 Solutions

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Abbott Laboratories
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Roche Holding AG
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Siemens Healthineers
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Becton Dickinson and Company
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Thermo Fisher Scientific
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Quidel Corporation
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 OraSure Technologies
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 bioMerieux
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Hologic
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Cepheid
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Bio-Rad Laboratories
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 PerkinElmer
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Danaher Corporation
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Qiagen
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Meridian Bioscience
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 GenMark Diagnostics
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Luminex Corporation
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Everlywell
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 LetsGetChecked
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Ellume
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us